AxoGen (AXGN) Misses Q4 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. LRCX
7. LVS
8. CSX
9. QGEN
10. KNX

Go back to AxoGen (AXGN) Misses Q4 EPS by 4c

Axogen, Inc. Reports 2018 Fourth Quarter and Full Year 2018 Financial Results

February 26, 2019 4:01 PM EST

Fourth Quarter Revenue of $23.4 million, representing 38% growth over prior yearFull Year 2018 Revenue of $83.9 million, representing 39% growth over prior year

ALACHUA, Fla., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today reported financial results and business highlights for the fourth quarter and full year ended December 31, 2018.

Fourth Quarter 2018 Financial Results and Recent Business Highlights

Revenue of $23.4 million, up 38% compared to fourth quarter 2017 revenue of $17.0... More